Detection, treatment, and monitoring of microbiome-induced metabolic dysfunction

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 12091704
APP PUB NO 20210340590A1
SERIAL NO

17271291

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Individuals consuming a prebiotic and who displayed improvements in blood glucose and/or insulin levels also displayed a decrease in the levels of the non-butyrate-producing Firmicutes genus of bacteria Sporacetigenium. Increasing levels of butyrate-producing Firmicutes genera were not consistently correlated with improvements in metabolism in response to prebiotic consumption. In the general population, Sporacetigenium levels are positively correlated with insulin levels.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MCPHARMA BIOTECH INCBOX 838 39 FREDRICK STREET CARBERRY R0K 0H0

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
McLaren, Derek Carberry, CA 8 2
McLaren, Earl Carberry, CA 8 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Mar 17, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 17, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 17, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00